9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice

[1] Polimeni JR(2018)Neuroimaging with ultra-high field MRI: present and future Neuroimage 168 1-6

[2] Uludağ K(2018)The world’s strongest MRI machines are pushing human imaging to new limits Nature 563 24-26

[3] Nowogrodzki A(2019)Safety of exposure to high static magnetic fields (2 T-12 T): a study on mice Eur Radiol 29 6029-6037

[4] Wang S(2018)Magnetic field direction differentially impacts the growth of different cell types Electromagn Biol Med 37 114-125

[5] Luo J(2022)Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib-induced KIT mutations in gastrointestinal stromal tumours Mol Oncol 16 1761-1774

[6] Lv H(2005)Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants Gastroenterology 128 270-279

[7] Zhang Z(2003)Imatinib mesylate causes hypopigmentation in the skin Cancer 98 2483-2487

[8] Yang J(2014)Ageing is a risk factor in imatinib mesylate cardiotoxicity Eur J Heart Fail 16 367-376

[9] Dong D(2020)Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies Mol Psychiatry 25 1487-1499

[10] Tian XF(2022)Stressful life events and distress in breast cancer: a 5-years follow-up Int J Clin Health Psychol 22 100303-365

[1] Polimeni JR(2018)Neuroimaging with ultra-high field MRI: present and future Neuroimage 168 1-6

[2] Uludağ K(2018)The world’s strongest MRI machines are pushing human imaging to new limits Nature 563 24-26

[3] Nowogrodzki A(2019)Safety of exposure to high static magnetic fields (2 T-12 T): a study on mice Eur Radiol 29 6029-6037

[4] Wang S(2018)Magnetic field direction differentially impacts the growth of different cell types Electromagn Biol Med 37 114-125

[5] Luo J(2022)Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib-induced KIT mutations in gastrointestinal stromal tumours Mol Oncol 16 1761-1774

[6] Lv H(2005)Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants Gastroenterology 128 270-279

[7] Zhang Z(2003)Imatinib mesylate causes hypopigmentation in the skin Cancer 98 2483-2487

[8] Yang J(2014)Ageing is a risk factor in imatinib mesylate cardiotoxicity Eur J Heart Fail 16 367-376

[9] Dong D(2020)Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies Mol Psychiatry 25 1487-1499

[10] Tian XF(2022)Stressful life events and distress in breast cancer: a 5-years follow-up Int J Clin Health Psychol 22 100303-365